Literature DB >> 35036665

Implementation of in silico toxicology protocols within a visual and interactive hazard assessment platform.

Glenn J Myatt1, Arianna Bassan2, Dave Bower1, Candice Johnson1, Scott Miller1, Manuela Pavan2, Kevin P Cross1.   

Abstract

Mechanistically-driven alternative approaches to hazard assessment invariably require a battery of tests, including both in silico models and experimental data. The decision-making process, from selection of the methods to combining the information based on the weight-of-evidence, is ideally described in published guidelines or protocols. This ensures that the application of such approaches is defendable to reviewers within regulatory agencies and across the industry. Examples include the ICH M7 pharmaceutical impurities guideline and the published in silico toxicology protocols. To support an efficient, transparent, consistent and fully documented implementation of these protocols, a new and novel interactive software solution is described to perform such an integrated hazard assessment based on public and proprietary information.

Entities:  

Year:  2021        PMID: 35036665      PMCID: PMC8754399          DOI: 10.1016/j.comtox.2021.100201

Source DB:  PubMed          Journal:  Comput Toxicol        ISSN: 2468-1113


  20 in total

1.  Establishing best practise in the application of expert review of mutagenicity under ICH M7.

Authors:  Chris Barber; Alexander Amberg; Laura Custer; Krista L Dobo; Susanne Glowienke; Jacky Van Gompel; Steve Gutsell; Jim Harvey; Masamitsu Honma; Michelle O Kenyon; Naomi Kruhlak; Wolfgang Muster; Lidiya Stavitskaya; Andrew Teasdale; Jonathan Vessey; Joerg Wichard
Journal:  Regul Toxicol Pharmacol       Date:  2015-08-04       Impact factor: 3.271

2.  Systematic analysis of large screening sets in drug discovery.

Authors:  Paul E Blower; Kevin P Cross; Michael A Fligner; Glenn J Myatt; Joseph S Verducci; Chihae Yang
Journal:  Curr Drug Discov Technol       Date:  2004-01

3.  The use of a chemistry-based profiler for covalent DNA binding in the development of chemical categories for read-across for genotoxicity.

Authors:  Steven J Enoch; Mark T D Cronin; Claire M Ellison
Journal:  Altern Lab Anim       Date:  2011-05       Impact factor: 1.303

4.  (Q)SAR assessments of potentially mutagenic impurities: a regulatory perspective on the utility of expert knowledge and data submission.

Authors:  Mark W Powley
Journal:  Regul Toxicol Pharmacol       Date:  2014-12-26       Impact factor: 3.271

5.  Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity.

Authors:  Ernst Ahlberg; Alexander Amberg; Lisa D Beilke; David Bower; Kevin P Cross; Laura Custer; Kevin A Ford; Jacky Van Gompel; James Harvey; Masamitsu Honma; Robert Jolly; Elisabeth Joossens; Raymond A Kemper; Michelle Kenyon; Naomi Kruhlak; Lara Kuhnke; Penny Leavitt; Russell Naven; Claire Neilan; Donald P Quigley; Dana Shuey; Hans-Peter Spirkl; Lidiya Stavitskaya; Andrew Teasdale; Angela White; Joerg Wichard; Craig Zwickl; Glenn J Myatt
Journal:  Regul Toxicol Pharmacol       Date:  2016-02-13       Impact factor: 3.271

6.  Skin sensitization in silico protocol.

Authors:  Candice Johnson; Ernst Ahlberg; Lennart T Anger; Lisa Beilke; Romualdo Benigni; Joel Bercu; Sol Bobst; David Bower; Alessandro Brigo; Sarah Campbell; Mark T D Cronin; Ian Crooks; Kevin P Cross; Tatyana Doktorova; Thomas Exner; David Faulkner; Ian M Fearon; Markus Fehr; Shayne C Gad; Véronique Gervais; Amanda Giddings; Susanne Glowienke; Barry Hardy; Catrin Hasselgren; Jedd Hillegass; Robert Jolly; Eckart Krupp; Liat Lomnitski; Jason Magby; Jordi Mestres; Lawrence Milchak; Scott Miller; Wolfgang Muster; Louise Neilson; Rahul Parakhia; Alexis Parenty; Patricia Parris; Alexandre Paulino; Ana Theresa Paulino; David W Roberts; Harald Schlecker; Reinhard Stidl; Diana Suarez-Rodrigez; David T Szabo; Raymond R Tice; Daniel Urbisch; Anna Vuorinen; Brian Wall; Thibaud Weiler; Angela T White; Jessica Whritenour; Joerg Wichard; David Woolley; Craig Zwickl; Glenn J Myatt
Journal:  Regul Toxicol Pharmacol       Date:  2020-07-01       Impact factor: 3.271

7.  In silico toxicology protocols.

Authors:  Glenn J Myatt; Ernst Ahlberg; Yumi Akahori; David Allen; Alexander Amberg; Lennart T Anger; Aynur Aptula; Scott Auerbach; Lisa Beilke; Phillip Bellion; Romualdo Benigni; Joel Bercu; Ewan D Booth; Dave Bower; Alessandro Brigo; Natalie Burden; Zoryana Cammerer; Mark T D Cronin; Kevin P Cross; Laura Custer; Magdalena Dettwiler; Krista Dobo; Kevin A Ford; Marie C Fortin; Samantha E Gad-McDonald; Nichola Gellatly; Véronique Gervais; Kyle P Glover; Susanne Glowienke; Jacky Van Gompel; Steve Gutsell; Barry Hardy; James S Harvey; Jedd Hillegass; Masamitsu Honma; Jui-Hua Hsieh; Chia-Wen Hsu; Kathy Hughes; Candice Johnson; Robert Jolly; David Jones; Ray Kemper; Michelle O Kenyon; Marlene T Kim; Naomi L Kruhlak; Sunil A Kulkarni; Klaus Kümmerer; Penny Leavitt; Bernhard Majer; Scott Masten; Scott Miller; Janet Moser; Moiz Mumtaz; Wolfgang Muster; Louise Neilson; Tudor I Oprea; Grace Patlewicz; Alexandre Paulino; Elena Lo Piparo; Mark Powley; Donald P Quigley; M Vijayaraj Reddy; Andrea-Nicole Richarz; Patricia Ruiz; Benoit Schilter; Rositsa Serafimova; Wendy Simpson; Lidiya Stavitskaya; Reinhard Stidl; Diana Suarez-Rodriguez; David T Szabo; Andrew Teasdale; Alejandra Trejo-Martin; Jean-Pierre Valentin; Anna Vuorinen; Brian A Wall; Pete Watts; Angela T White; Joerg Wichard; Kristine L Witt; Adam Woolley; David Woolley; Craig Zwickl; Catrin Hasselgren
Journal:  Regul Toxicol Pharmacol       Date:  2018-04-17       Impact factor: 3.271

8.  Genetic toxicology in silico protocol.

Authors:  Catrin Hasselgren; Ernst Ahlberg; Yumi Akahori; Alexander Amberg; Lennart T Anger; Franck Atienzar; Scott Auerbach; Lisa Beilke; Phillip Bellion; Romualdo Benigni; Joel Bercu; Ewan D Booth; Dave Bower; Alessandro Brigo; Zoryana Cammerer; Mark T D Cronin; Ian Crooks; Kevin P Cross; Laura Custer; Krista Dobo; Tatyana Doktorova; David Faulkner; Kevin A Ford; Marie C Fortin; Markus Frericks; Samantha E Gad-McDonald; Nichola Gellatly; Helga Gerets; Véronique Gervais; Susanne Glowienke; Jacky Van Gompel; James S Harvey; Jedd Hillegass; Masamitsu Honma; Jui-Hua Hsieh; Chia-Wen Hsu; Tara S Barton-Maclaren; Candice Johnson; Robert Jolly; David Jones; Ray Kemper; Michelle O Kenyon; Naomi L Kruhlak; Sunil A Kulkarni; Klaus Kümmerer; Penny Leavitt; Scott Masten; Scott Miller; Chandrika Moudgal; Wolfgang Muster; Alexandre Paulino; Elena Lo Piparo; Mark Powley; Donald P Quigley; M Vijayaray Reddy; Andrea-Nicole Richarz; Benoit Schilter; Ronald D Snyder; Lidiya Stavitskaya; Reinhard Stidl; David T Szabo; Andrew Teasdale; Raymond R Tice; Alejandra Trejo-Martin; Anna Vuorinen; Brian A Wall; Pete Watts; Angela T White; Joerg Wichard; Kristine L Witt; Adam Woolley; David Woolley; Craig Zwickl; Glenn J Myatt
Journal:  Regul Toxicol Pharmacol       Date:  2019-06-11       Impact factor: 3.271

9.  Transitioning to composite bacterial mutagenicity models in ICH M7 (Q)SAR analyses.

Authors:  Curran Landry; Marlene T Kim; Naomi L Kruhlak; Kevin P Cross; Roustem Saiakhov; Suman Chakravarti; Lidiya Stavitskaya
Journal:  Regul Toxicol Pharmacol       Date:  2019-10-03       Impact factor: 3.271

10.  Principles and procedures for handling out-of-domain and indeterminate results as part of ICH M7 recommended (Q)SAR analyses.

Authors:  Alexander Amberg; Roxanne V Andaya; Lennart T Anger; Chris Barber; Lisa Beilke; Joel Bercu; Dave Bower; Alessandro Brigo; Zoryanna Cammerer; Kevin P Cross; Laura Custer; Krista Dobo; Helga Gerets; Véronique Gervais; Susanne Glowienke; Stephen Gomez; Jacky Van Gompel; James Harvey; Catrin Hasselgren; Masamitsu Honma; Candice Johnson; Robert Jolly; Raymond Kemper; Michelle Kenyon; Naomi Kruhlak; Penny Leavitt; Scott Miller; Wolfgang Muster; Russell Naven; John Nicolette; Alexis Parenty; Mark Powley; Donald P Quigley; M Vijayaraj Reddy; Jennifer C Sasaki; Lidiya Stavitskaya; Andrew Teasdale; Alejandra Trejo-Martin; Sandy Weiner; Dennie S Welch; Angela White; Joerg Wichard; David Woolley; Glenn J Myatt
Journal:  Regul Toxicol Pharmacol       Date:  2018-12-15       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.